Literature DB >> 33079276

Increasing detection of rotavirus G2P[4] strains in Nizhny Novgorod, Russia, between 2016 and 2019.

Olga V Morozova1, Tatiana A Sashina2, Natalia V Epifanova2, Alexander Yu Kashnikov2, Nadezhda A Novikova2.   

Abstract

Rotavirus infection is one of the leading causes of acute gastroenteritis in children in their first years of life. We studied the genotypic diversity of rotavirus A (RVA) strains in Nizhny Novgorod, Russia, during the period 2016-19. In total, 4714 samples of faeces from children admitted to the Nizhny Novgorod Hospital for Infectious Diseases with acute gastroenteritis were examined. The share of rotavirus-positive samples was 31.5% in 2016-17. It decreased to 21.6% in 2018-19. In Nizhny Novgorod, all six global types of RVA were detected (G1P[8], G2P[4], G3P[8], G4P[8], G9P[8] and G12P[8]), as well as sporadic samples with genotypes G9P[4], G3P[9], G9P[9], G8P[8], G2P[8], G4P[4], G3P[9]. The fraction of strains with genotype G2P[4] gradually increased from 5.9% in 2016-17 to 39.1% in 2018-19. Simultaneously, the proportion of G9P[8] strains decreased from 63.2% to 27.7% in the same period. Phylogenetic analysis showed that rotaviruses with the G2P[4] genotype carried ubiquitous alleles of the VP7 and VP4 genes during the period of their prevalence: G2-IVa-1 and G2-IVa-3; P[4]-IVa and P[4]-IVb. As rotavirus vaccination is not widely used in the region because it is not included in the national vaccination calendar in Russia so far, the increase in the number of G2P[4] RVA is likely due to natural strain fluctuations.

Entities:  

Year:  2020        PMID: 33079276     DOI: 10.1007/s00705-020-04853-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  39 in total

1.  Rotavirus genotypes co-circulating in Europe between 2006 and 2009 as determined by EuroRotaNet, a pan-European collaborative strain surveillance network.

Authors:  M Iturriza-Gómara; T Dallman; K Bányai; B Böttiger; J Buesa; S Diedrich; L Fiore; K Johansen; M Koopmans; N Korsun; D Koukou; A Kroneman; B László; M Lappalainen; L Maunula; A Mas Marques; J Matthijnssens; S Midgley; Z Mladenova; S Nawaz; M Poljsak-Prijatelj; P Pothier; F M Ruggeri; A Sanchez-Fauquier; A Steyer; I Sidaraviciute-Ivaskeviciene; V Syriopoulou; A N Tran; V Usonis; M VAN Ranst; A DE Rougemont; J Gray
Journal:  Epidemiol Infect       Date:  2010-08-16       Impact factor: 2.451

Review 2.  Immune responses to rotavirus infection and vaccination and associated correlates of protection.

Authors:  Ulrich Desselberger; Hans-Iko Huppertz
Journal:  J Infect Dis       Date:  2011-01-15       Impact factor: 5.226

3.  Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL®).

Authors:  Sameer P Naik; Jagdish K Zade; Rajendra N Sabale; Sambhaji S Pisal; Ravi Menon; Subhash G Bankar; Sunil Gairola; Rajeev M Dhere
Journal:  Vaccine       Date:  2017-04-20       Impact factor: 3.641

4.  Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009.

Authors:  Daniel C Payne; Mary Allen Staat; Kathryn M Edwards; Peter G Szilagyi; Geoffrey A Weinberg; Caroline B Hall; James Chappell; Aaron T Curns; Mary Wikswo; Jacqueline E Tate; Benjamin A Lopman; Umesh D Parashar
Journal:  Clin Infect Dis       Date:  2011-06-23       Impact factor: 9.079

5.  G2 rotavirus within an emergent VP7 evolutionary lineage circulating in children with acute diarrhea in Guangxi Province of China, 2014.

Authors:  Hui Jin Dong; Yuan Qian; You Zhang; Lin Qing Zhao; Ru Nan Zhu; Yi Nong; Zhao Jun Mo; Rong Cheng Li
Journal:  Arch Virol       Date:  2016-04-21       Impact factor: 2.574

6.  Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age.

Authors:  Jie Li; Yi Zhang; Yang Yang; Zhichao Liang; Yi Tian; Baiwei Liu; Zhiyong Gao; Lei Jia; Lijuan Chen; Quanyi Wang
Journal:  Vaccine       Date:  2019-05-20       Impact factor: 3.641

Review 7.  Genotype constellation and evolution of group A rotaviruses infecting humans.

Authors:  Jelle Matthijnssens; Marc Van Ranst
Journal:  Curr Opin Virol       Date:  2012-06-09       Impact factor: 7.090

8.  Global Routine Vaccination Coverage, 2018.

Authors:  Megan Peck; Marta Gacic-Dobo; Mamadou S Diallo; Yoann Nedelec; Samir S Sodha; Aaron S Wallace
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2019-10-25       Impact factor: 17.586

9.  Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments.

Authors:  Jelle Matthijnssens; Max Ciarlet; Mustafizur Rahman; Houssam Attoui; Krisztián Bányai; Mary K Estes; Jon R Gentsch; Miren Iturriza-Gómara; Carl D Kirkwood; Vito Martella; Peter P C Mertens; Osamu Nakagomi; John T Patton; Franco M Ruggeri; Linda J Saif; Norma Santos; Andrej Steyer; Koki Taniguchi; Ulrich Desselberger; Marc Van Ranst
Journal:  Arch Virol       Date:  2008-07-05       Impact factor: 2.574

10.  ROTAVAC® does not interfere with the immune response to childhood vaccines in Indian infants: A randomized placebo controlled trial.

Authors:  Temsunaro Rongsen Chandola; Sunita Taneja; Nidhi Goyal; Kalpana Antony; Kiran Bhatia; Deepak More; Nita Bhandari; Iksung Cho; Krishna Mohan; Sai Prasad; Gvja Harshavardhan; Tataji Surender Rao; Sudhanshu Vrati; Maharaj Kishan Bhan
Journal:  Heliyon       Date:  2017-05-16
View more
  1 in total

1.  Prevalence and Genetic Diversity of Group A Rotavirus Genotypes in Moscow (2019-2020).

Authors:  Anton Yuzhakov; Ksenia Yuzhakova; Nadezhda Kulikova; Lidia Kisteneva; Stanislav Cherepushkin; Svetlana Smetanina; Marina Bazarova; Anton Syroeshkin; Tatiana Grebennikova
Journal:  Pathogens       Date:  2021-05-30
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.